|Day's Range||26.40 - 28.23|
|52 Week Range||8.75 - 28.45|
|PE Ratio (TTM)||1,290.95|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Celgene Corporation (CELG) beat earnings and revenue estimates in the second quarter and upped view.
Glaxo's (GSK) second-quarter earnings beat estimates, while revenues miss the same. The company cuts its core 2017 earnings growth at CER, with no Advair generics launched this year.
Gilead Sciences' (GILD) better-than-expected second-quarter results boosted investors sentiments.